KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Consolidated Net Income: 2010-2025

Historic Consolidated Net Income for Emergent BioSolutions (EBS) over the last 16 years, with Sep 2025 value amounting to $51.2 million.

  • Emergent BioSolutions' Consolidated Net Income fell 55.40% to $51.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.9 million, marking a year-over-year increase of 136.35%. This contributed to the annual value of -$190.6 million for FY2024, which is 74.94% up from last year.
  • Per Emergent BioSolutions' latest filing, its Consolidated Net Income stood at $51.2 million for Q3 2025, which was up 526.67% from -$12.0 million recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Consolidated Net Income ranged from a high of $177.9 million in Q4 2021 and a low of -$283.1 million during Q2 2024.
  • Over the past 3 years, Emergent BioSolutions' median Consolidated Net Income value was -$31.3 million (recorded in 2024), while the average stood at -$76.7 million.
  • Per our database at Business Quant, Emergent BioSolutions' Consolidated Net Income skyrocketed by 657.60% in 2021 and then slumped by 4,932.43% in 2023.
  • Over the past 5 years, Emergent BioSolutions' Consolidated Net Income (Quarterly) stood at $177.9 million in 2021, then crashed by 137.66% to -$67.0 million in 2022, then grew by 26.12% to -$49.5 million in 2023, then surged by 36.77% to -$31.3 million in 2024, then plummeted by 55.40% to $51.2 million in 2025.
  • Its Consolidated Net Income stands at $51.2 million for Q3 2025, versus -$12.0 million for Q2 2025 and $68.0 million for Q1 2025.